Characterization and regulation of the human ML(1A) melatonin receptor stably expressed in Chinese hamster ovary cells

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 166-174

  Witt Enderby, Paula A ^a   Dubocovich, Margarita L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FORSKOLIN; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; PERTUSSIS TOXIN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHO CELL; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SUPRACHIASMATIC NUCLEUS;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; FORSKOLIN; HUMANS; KINETICS; MELATONIN; RECEPTORS, CELL SURFACE; RECEPTORS, MELATONIN; RECOMBINANT PROTEINS; TRANSFECTION; TRYPTAMINES;

EID: 0029895791     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Krause, D. N., and M. L. Dubocovich. Melatonin receptors. Annu. Rev. Pharmacol. Toxicol. 31:549-568 (1991).
2. Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:151-180 (1991).
3. Morgan, P. J., P. Barrett, H. E. Howell, and R. Helliwell. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int. 24:101-146 (1994).
4. Reppert, S. M., D. R. Weaver, S. A. Rivkees, and E. G. Stopa. Putative melatonin receptors in a human biological clock. Science (Washington D. C.) 242:78-81 (1988).
5. Reppert, S. M., D. R. Weaver, and T. Ebisawa. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177-1185 (1994).
6. 1b melatonin receptor. Proc. Natl. Acad. Sci. USA 92:8734-8738 (1995).
7. Lewy, A. J., S. Ahmed, J. M. Latham-Jackson, and R. L. Sack. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 9:380-392 (1992).
8. Dubocovich, M. L. Pharmacology and function of melatonin receptors. FASEB J. 2:2765-2773 (1988).
9. Dubocovich, M. L. Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 16:50-56 (1995).
10. Popova, J. S., and M. L. Dubocovich. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J. Neurochem. 64:130-138 (1995).
11. Ebisawa, T., S. Karne, M. R. Lerner, and S. M. Reppert. Expression cloning of a high affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl. Acad. Sci. USA 91:6133-6137 (1994).
12. Slaugenhaupt, S., A. L. Roca, C. B. Liebert, M. R. Altherr, J. F. Gusella, and S. M. Reppert. Mapping of the gene for the Mel1A-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1). Genomics 27:355-357 (1995).
13. Gauer, F., M. Masson-Pevet, D. J. Skene, B. Vivien-Roels, and P. Pevet. Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei: evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology 57:120-126 (1993).
14. Gauer, R., M. Masson-Pevet, and P. Pevet. Melatonin receptor density is regulated in rat pars tuberalis and suprachiasmatic nuclei by melatonin itself. Brain Res. 602:153-156 (1993).
15. Gauer, F., M. Masson-Pevet, J. Stehle, and P. Pevet. Daily variations of melatonin receptor density of rat pars tuberalis and suprachiasmatic nuclei are distinctly regulated. Brain Res. 641:92-98 (1994).
16. Hazlerigg, D. G., A. Gonzalez-Brito, W. Lawson, M. H. Hastings, and P. J. Morgan. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 132:285-292 (1993).
17. Tenn, C., and L. P. Niles. Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress. Mol. Cell. Endocrinol. 98:43-48 (1993).
18. Saloman, Y. Adenylate cyclase assay. Adv. Cyclic Nucleotide Res. 10:35-54 (1979).
19. Johnson, R. A., and Y. Saloman. Determination of adenylyl cyclase activity. Methods Enzym. 195:3-21 (1991).
20. 3H]cAMP in cell monolayers, cell suspensions, and tissue slices. Methods Enzym. 195:22-28 (1991).
21. Dubocovich, M. L. Luzindole (N-0774): a novel melatonin receptor antagonist. J. Pharmacol. Exp. Ther. 246:902-919 (1988).
22. Ying, S.-W., L. Niles, D. Pickering, and M. Ye. Involvement of multiple sulfhydryl groups in melatonin signal transduction in chick brain. Mol. Cell. Endocrinol. 85:53-63 (1992).
23. Howell, H. E., B. Guardiola, P. Renard, and P. J. Morgan. Napthalenic ligands reveal melatonin binding site heterogeneity. Endocrinology 2:979-988 (1995).
24. Ying, S.-W., L. Niles, and C. Crocker. Human malignant melanoma cells express high affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur. J. Pharmacol. 246:89-96 (1993).
25. Niles, L. P., and F. Hashemi. Picomolar-affinity binding and inhibition of adenylate cyclase activity by melatonin in Syrian hamster hypothalamus. Cell. Mol. Neurobiol, 10:553-557 (1990).
26. Niles, L. P., and F. S. Hashemi. Pharmacological inhibition of forskolinstimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam. Biochem. Pharmacol. 40:2701-2705 (1990).
27. Yung, L. Y., S.-T. Tsim, and Y. H. Wong. Stimulation of cAMP accumulation by the cloned Xenopus melatonin receptor through Gi and Gz proteins. FEBS Lett. 372:99-102 (1995).
28. Faillace, M., P. Keller, M. I. Sarmiento, L. N. Siri, and R. E. Rosenstein. Diurnal variations in cyclic AMP and melatonin content of golden hamster retina. J. Neurochem. 62:1995-2000 (1994).
29. Prather, P. L., T. M. McGinn, P. A. Claude, L. Y. Liu-Chen, H. H. Loh, and P. Y. Law. Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G proteins is not specific for any individual Ga subunit and is similar to that of other opioid receptors. Mol. Brain Res. 29:336-346 (1995).
30. i protein subtypes regulate a single effector mechanism. Mol. Pharmacol. 40:707-711 (1991).
31. Morgan, P. J., W, Davidson, W. Lawson, and P. Barrett. Both pertussis toxin-sensitive and -insensitive G proteins link melatonin receptor to inhibition of adenylate cyclase in the ovine pars tuberalis. J. Neuroendocrinol. 2:1-4 (1991).
32. Benitez-King, G., and F. Anton-Tay. Calmodulin mediates cytoskeletal effects. Experientia 49:635-641 (1993).
33. Tang, W.-J., and A. G. Gilman. Adenylyl cyclases. Cell 70:869-872 (1992).
34. Kenakin, T. Stimulus-response mechanisms, in Pharmacologic Analysis of Drug-Receptor Interaction (T. Kenakin, ed.). Raven Press, New York, 46-49 (1993).
35. Lohse, M. J., K.-N. Klotz, and U. Schwabe. Agonist photoaffinity labeling A1 adenosine receptors: persistent activation reveals spare receptors. Mol Pharmacol. 30:403-409 (1986).
36. Baker, S. P., and P. Posner. Irreversible binding of acetylcholine mustard to cardiac cholinergic muscarinic receptors. Mol. Pharmacol. 30:411-418 (1986).
37. Nerme, V., Y. Severne, T. Abrahamsson, and G. Vauquelin. Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding. Biochem. Pharmacol. 34:2917-2922 (1985).
38. Severne, Y., A. Ijzerman, V. Nerme, H. Timmerman, and G. Vauquelin. Shallow agonist competition binding curves for β-adrenergic receptors: the role of tight agonist binding. Mol. Pharmacol. 31:69-73 (1987).
39. Wu-Wong, J. R., W. J. Chiou, S. R. Magnuson, and T. J. Opgenorth. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim. Biophys. Acta 1224:288-294 (1894).
40. Wu-Wong, J. R., W. J. Chiou, K. E. Naugles, Jr., and T. J. Opgenorth. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist. Life Sci. 54:1727-1734 (1994).
41. Chun, M., U. K. Liyanage, M. P. Lisanti, and H. F. Lodish. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91:11728-11732 (1994).
42. Barrett, P., A. MacLean, and P. J. Morgan. Evidence for multiple forms of melatonin receptor-G protein complexes by solubilization and gel electrophoresis. J. Neuroendocrinol. 6:506-515 (1994).
43. Steindl, P. E., B. Finn, B. Bendok, S. Rothke, P. C. Zee, and A. T. Blei. Disruption the diurnal rhythm of plasma melatonin in cirrhosis. Ann. Intern. Med. 123:274-277 (1995).